Catechol-O-methyltransferase valine158methionine polymorphism moderates methylphenidate effects on oppositional symptoms in boys with attention-deficit/hyperactivity disorder

Biological Psychiatry

Volumn 70, Issue 3, 2011, Pages 216-221

  Salatino Oliveira, Angélica ^a   Genro, Julia P ^a   Zeni, Cristian ^b   Polanczyk, Guilherme V ^b   Chazan, Rodrigo ^b   Guimarães, Ana P ^a   Callegari Jacques, Sidia M ^a   Rohde, Luis A ^b   Hutz, Mara H ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

ADHD; COMT; methylphenidate; pharmacogenetics; Val158Met

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; METHYLPHENIDATE; VALINE;

ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD PSYCHIATRY; COMORBIDITY; DNA POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME;

ADOLESCENT; ADOLESCENT BEHAVIOR; ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CATECHOL O-METHYLTRANSFERASE; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD BEHAVIOR; CHILD, PRESCHOOL; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; METHYLPHENIDATE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79960227004     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2011.03.025     Document Type: Article

References (52)

1. G. Polanczyk, M.S. de Lima, B.L. Horta, J. Biederman, and L.A. Rohde The worldwide prevalence of ADHD: A systematic review and metaregression analysis Am J Psychiatry 164 2007 942 948 (Pubitemid 46972911)
2. J. Biederman, and S.V. Faraone Attention-deficit hyperactivity disorder Lancet 366 2005 237 248 (Pubitemid 40981053)
3. A. Thapar, M. van den Bree, T. Fowler, K. Langley, and N. Whittinger Predictors of antisocial behaviour in children with attention deficit hyperactivity disorder Eur Child Adolesc Psychiatry 15 2006 118 125 (Pubitemid 43355170)
4. I. Souza, M.A. Pinheiro, D. Denardin, P. Mattos, and L.A. Rohde Attention-deficit/hyperactivity disorder and comorbidity in Brazil: Comparisons between two referred samples Eur Child Adolesc Psychiatry 13 2004 243 248 (Pubitemid 39279156)
5. A. Caspi, K. Langley, B. Milne, T.E. Moffitt, M. O'Donovan, and M.J. Owen A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit/hyperactivity disorder Arch Gen Psychiatry 65 2008 203 210 (Pubitemid 351214319)
6. A.F. Arnsten, and B.M. Li Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions Biol Psychiatry 57 2005 1377 1384 (Pubitemid 40798558)
7. M.V. Solanto Dopamine dysfunction in AD/HD: Integrating clinical and basic neuroscience research Behav Brain Res 130 2002 65 71 (Pubitemid 34195322)
8. S.R. Pliszka The neuropsychopharmacology of attention-deficit/ hyperactivity disorder Biol Psychiatry 57 2005 1385 1390 (Pubitemid 40798559)
9. R.J. Nelson, and B.C. Trainor Neural mechanisms of aggression Nat Rev Neurosci 8 2007 536 546 (Pubitemid 46985366)
10. J. Prince Catecholamine dysfunction in attention-deficit/hyperactivity disorder: An update J Clin Psychopharmacol 28 2008 S39 S45
11. T.E. Wilens Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder J Clin Psychopharmacol 28 2008 S46 S53
12. C.M. Szobot, C. Ketzer, M.A. Parente, J. Biederman, and L.A. Rohde The acute effect of methylphenidate in Brazilian male children and adolescents with ADHD: A randomized clinical trial J Atten Disord 8 2004 37 43 (Pubitemid 40081858)
13. L.S. Goldman, M. Genel, R.J. Bezman, and P.J. Slanetz Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents Council on Scientific Affairs, American Medical Association JAMA 279 1998 1100 1107 (Pubitemid 28177819)
14. M.A. Serra-Pinheiro, P. Mattos, I. Souza, G. Pastura, and F. Gomes The effect of methylphenidate on oppositional defiant disorder comorbid with attention deficit/hyperactivity disorder Arq Neuro Psiquiatr 62 2004 399 402 (Pubitemid 38923841)
15. P.S. Jensen, L.E. Arnold, J.M. Swanson, B. Vitiello, H.B. Abikoff, and L.L. Greenhill 3-Year follow-up of the NIMH MTA Study J Am Acad Child Adolesc Psychiatry 46 2007 989 1002 (Pubitemid 47220683)
16. C.W. Berridge, D.M. Devilbiss, M.E. Andrzejewski, A.F. Arnsten, A.E. Kelley, and B. Schmeichel Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function Biol Psychiatry 60 2006 1111 1120 (Pubitemid 44647216)
17. J.A. Morón, A. Brockington, R.A. Wise, B.A. Rocha, and B.T. Hope Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: Evidence from knock-out mouse lines J Neurosci 22 2002 389 395 (Pubitemid 34049076)
18. D. Mier, P. Kirsch, and A. Meyer-Lindenberg Neural substrates of pleiotropic action of genetic variation in COMT: A meta-analysis Mol Psychiatry 15 2010 918 927
19. 158Met polymorphism and socioeconomic status interact to predict attention deficit/hyperactivity problems in children aged 1014 Eur Child Adolesc Psychiatry 19 2010 549 557
20. A. Diamond Consequences of variations in genes that affect dopamine in prefrontal cortex Cereb Cortex 17 suppl 1 2007 i161 i170
21. J. Tenhunen, M. Salminen, K. Lundström, T. Kiviluoto, R. Savolainen, and I. Ulmanen Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters Eur J Biochem 223 1994 1049 1059 (Pubitemid 24263190)
22. T. Lotta, J. Vidgren, C. Tilgmann, I. Ulmanen, K. Melén, I. Julkunen, and J. Taskinen Kinetics of human soluble and membrane-bound catechol O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme Biochemistry 34 1995 4202 4210
23. J. Chen, B.K. Lipska, N. Halim, Q.D. Ma, M. Matsumoto, and S. Melhem Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain Am J Hum Genet 75 2004 807 821 (Pubitemid 39390488)
24. T.S. Nadder, M. Rutter, J.L. Silberg, H.H. Maes, and L.J. Eaves Genetic effects on the variation and covariation of attention deficit-hyperactivity disorder (ADHD) and oppositional-defiant disorder/conduct disorder (Odd/CD) symptomatologies across informant and occasion of measurement Psychol Med 32 2002 39 53 (Pubitemid 33150502)
25. T. Fowler, K. Langley, F. Rice, M.B.M. van den Bree, K. Ross, and L.S. Wilkinson Psychopathy traits in adolescents with childhood ADHD: The contribution of genotypes affecting MAOA, 5HTT and COMT activity Psychiatr Genet 19 2009 312 319
26. A. Thapar, K. Langley, T. Fowler, F. Rice, D. Turic, and N. Whittinger Catechol O-methyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with attention-deficit/hyperactivity disorder Arch Gen Psychiatry 62 2005 1275 1278 (Pubitemid 41586927)
27. 158Met polymorphism associated with conduct disorder and ADHD symptoms, among adolescent male delinquents Psychiatr Genet 20 2010 20 24
28. G. Polanczyk, C. Zeni, J.P. Genro, T. Roman, M.H. Hutz, and L.A. Rohde Attention-deficit/hyperactivity disorder: Advancing on pharmacogenomics Pharmacogenomics 6 2005 225 234 (Pubitemid 40601626)
29. 158Met polymorphism is associated with methylphenidate response in ADHD children Am J Med Genet B Neuropsychiatr Genet 147B 2008 1431 1435
30. C.P. Zeni, A.P. Guimares, G.V. Polanczyk, J.P. Genro, T. Roman, M.H. Hutz, and L.A. Rohde No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention-deficit/hyperactivity disorder Am J Med Genet B Neuropsychiatr Genet 144B 2007 391 394 (Pubitemid 46646664)
31. G. Polanczyk, C. Zeni, J.P. Genro, A.P. Guimares, T. Roman, M.H. Hutz, and L.A. Rohde Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder Arch Gen Psychiatry 64 2007 218 224 (Pubitemid 46220779)
32. J.A. Gogos, M. Morgan, V. Luine, M. Santha, S. Ogawa, D. Pfaff, and M. Karayiorgou Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior Proc Natl Acad Sci U S A 95 1998 9991 9996 (Pubitemid 28415282)
33. P.J. Harrison, and E.M. Tunbridge Catechol-O-methyltransferase (COMT): A gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders Neuropsychopharmacology 33 2008 3037 3045
34. J. Biederman, J.W. Kim, A.E. Doyle, E. Mick, J. Fagerness, J.W. Smoller, and S.V. Faraone Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: A preliminary study Am J Med Genet B Neuropsychiatr Genet 147B 2008 1511 1518
35. J.M. Swanson, H.C. Kraemer, S.P. Hinshaw, L.E. Arnold, C.K. Conners, and H.B. Abikoff Clinical relevance of the primary findings of the MTA: Success rates based on severity of ADHD and ODD symptoms at the end of treatment J Am Acad Child Adolesc Psychiatry 40 2001 168 179 (Pubitemid 32111020)
36. A.P. Guimares, C. Zeni, G. Polanczyk, J.P. Genro, T. Roman, L.A. Rohde, and M.H. Hutz MAOA is associated with methylphenidate improvement of oppositional symptoms in boys with attention deficit hyperactivity disorder Int J Neuropsychopharmacol 12 2009 709 714
37. L.A. Rohde ADHD in Brazil: The DSM-IV criteria in a culturally different population J Am Acad Child Adolesc Psychiatry 41 2002 1131 1133 (Pubitemid 38338062)
38. H. Kunugi, S. Nanko, A. Ueki, E. Otsuka, M. Hattori, and F. Hoda High and low activity alleles of catechol-O-methyltransferase gene: Ethnic difference and possible association with Parkinson's disease Neurosci Lett 221 1997 202 204 (Pubitemid 27049233)
39. R.D. Gibbons, D. Hedeker, I. Elkin, C. Waternaux, H.C. Kraemer, and J.B. Greenhouse Some conceptual and statistical issues in analysis of longitudinal psychiatric data Application to the NIMH treatment of Depression Collaborative Research Program dataset Arch Gen Psychiatry 50 1993 739 750 (Pubitemid 23263811)
40. C.H. Mallinckrodt, W.S. Clark, and S.R. David Accounting for dropout bias using mixed-effects models J Biopharm Stat 11 2001 9 21 (Pubitemid 32642825)
41. R. Gueorguieva, and J.H. Krystal Move over ANOVA: Progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry Arch Gen Psychiatry 61 2004 310 317 (Pubitemid 38295833)
42. J.S. Vles, F.J. Feron, J.G. Hendriksen, J. Jolles, M.J. van Kroonenburgh, and W.E. Weber Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD) Neuropediatrics 34 2003 77 80 (Pubitemid 36597126)
43. C.L. Coulter, H.K. Happe, and L.C. Murrin Postnatal development of the dopamine transporter: A quantitative autoradiographic study Brain Res Dev Brain Res 92 1996 172 181 (Pubitemid 26160365)
44. A.F. Arnsten Stimulants: Therapeutic actions in ADHD Neuropsychopharmacology 31 2006 2376 2383 (Pubitemid 44607054)
45. V. Engert, and J.C. Pruessner Dopaminergic and noradrenergic contributions to functionality in ADHD: The role of methylphenidate Curr Neuropharmacol 6 2008 322 328
46. D.D. Han, and H.H. Gu Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs BMC Pharmacol 6 2006 6
47. A. Raine Annotation: The role of prefrontal deficits, low autonomic arousal, and early health factors in the development of antisocial and aggressive behavior in children J Child Psychol Psychiatry 43 2002 417 434 (Pubitemid 36939229)
48. A. Caspi, J. McClay, T.E. Moffitt, J. Mill, J. Martin, and I.W. Craig Role of genotype in the cycle of violence in maltreated children Science 297 2002 851 2854
49. MTA Cooperative Group A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD Arch Gen Psychiatry 56 1999 1073 1086
50. J.D. Burke, A.E. Hipwell, and R. Loeber Dimensions of oppositional defiant disorder as predictors of depression and conduct disorder in preadolescent girls J Am Acad Child Adolesc Psychiatry 49 2010 484 492
51. R. Loeber, J.D. Burke, and D.A. Pardini Development and etiology of disruptive and delinquent behavior Annu Rev Clin Psychol 5 2009 291 310
52. C. Kieling, J.P. Genro, M.H. Hutz, and L.A. Rohde A current update on ADHD pharmacogenomics Pharmacogenomics 11 2010 407 419